WO2000003994A3 - Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them - Google Patents
Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them Download PDFInfo
- Publication number
- WO2000003994A3 WO2000003994A3 PCT/EP1999/004886 EP9904886W WO0003994A3 WO 2000003994 A3 WO2000003994 A3 WO 2000003994A3 EP 9904886 W EP9904886 W EP 9904886W WO 0003994 A3 WO0003994 A3 WO 0003994A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- biphenylsulfonyl
- preparation process
- diagnostic agent
- imidazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL99346165A PL346165A1 (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
DK99934669T DK1097140T3 (en) | 1998-07-18 | 1999-07-10 | Imidazole derivatives with biphenyl substitution, process for their preparation, their use as a drug or diagnostic and drug containing them |
HU0103184A HUP0103184A3 (en) | 1998-07-18 | 1999-07-10 | Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them |
DE59908753T DE59908753D1 (en) | 1998-07-18 | 1999-07-10 | IMIDAZOLE DERIVATIVES WITH BIPHENYLSULFONYL SUBSTITUTION, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE OR DIAGNOSTIC AND THE MEDICINE CONTAINING IT |
US09/743,941 US6372917B1 (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
JP2000560101A JP4567884B2 (en) | 1998-07-18 | 1999-07-10 | Imidazole derivatives having a biphenylsulfonyl substitution, processes for their preparation, their use as medicaments or diagnostics, and medicaments containing them |
KR1020017000751A KR20010070984A (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
CA002338039A CA2338039A1 (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
BR9912139-5A BR9912139A (en) | 1998-07-18 | 1999-07-10 | Imidazole derivatives with biphenylsulfonyl substitution process for its preparation its use as a medicine or diagnosis, as well as medicine containing it |
EP99934669A EP1097140B1 (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
MXPA01000534A MXPA01000534A (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them. |
AU50364/99A AU764784B2 (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
AT99934669T ATE260901T1 (en) | 1998-07-18 | 1999-07-10 | IMIDAZOLE DERIVATIVES WITH BIPHENYLSULFONYL SUBSTITUTION, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICATION OR DIAGNOSTIC AND THE MEDICINAL CONTAINING THEM |
HK01109111A HK1038352A1 (en) | 1998-07-18 | 2001-12-27 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19832429.4 | 1998-07-18 | ||
DE19832429A DE19832429A1 (en) | 1998-07-18 | 1998-07-18 | New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000003994A2 WO2000003994A2 (en) | 2000-01-27 |
WO2000003994A3 true WO2000003994A3 (en) | 2000-04-20 |
Family
ID=7874575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/004886 WO2000003994A2 (en) | 1998-07-18 | 1999-07-10 | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
Country Status (23)
Country | Link |
---|---|
US (1) | US6372917B1 (en) |
EP (1) | EP1097140B1 (en) |
JP (1) | JP4567884B2 (en) |
KR (1) | KR20010070984A (en) |
CN (1) | CN1177827C (en) |
AR (1) | AR019404A1 (en) |
AT (1) | ATE260901T1 (en) |
AU (1) | AU764784B2 (en) |
BR (1) | BR9912139A (en) |
CA (1) | CA2338039A1 (en) |
DE (2) | DE19832429A1 (en) |
DK (1) | DK1097140T3 (en) |
ES (1) | ES2217779T3 (en) |
HK (1) | HK1038352A1 (en) |
HU (1) | HUP0103184A3 (en) |
ID (1) | ID27023A (en) |
MX (1) | MXPA01000534A (en) |
PL (1) | PL346165A1 (en) |
PT (1) | PT1097140E (en) |
RU (1) | RU2246489C2 (en) |
TR (1) | TR200100123T2 (en) |
WO (1) | WO2000003994A2 (en) |
ZA (1) | ZA200100318B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19832429A1 (en) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
DE19832428A1 (en) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
KR20030024259A (en) * | 2001-09-17 | 2003-03-26 | 주식회사케이텍정보통신 | Electronic toll collection system |
US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
DE10206354A1 (en) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Use of inhibitors of the sodium-dependent chloride-bicarbonate exchanger for the treatment of thrombotic and inflammatory diseases |
DE10356717A1 (en) * | 2003-12-02 | 2005-07-07 | Aventis Pharma Deutschland Gmbh | Process for the preparation of (3-oxo-2,3-dihydro-1H-isoindol-1-yl) -acetylguanidine derivatives |
US7531569B2 (en) * | 2003-12-02 | 2009-05-12 | Sanofi-Aventis Deutschland Gmbh | Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0479479A1 (en) * | 1990-10-01 | 1992-04-08 | Merck & Co. Inc. | Imadazole angiotensin II antagonists incorporating acidic functional groups |
EP0503838A2 (en) * | 1991-03-08 | 1992-09-16 | Merck & Co. Inc. | Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists |
WO1992020662A1 (en) * | 1991-05-10 | 1992-11-26 | Merck & Co., Inc. | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
WO1994003435A1 (en) * | 1992-08-06 | 1994-02-17 | E.I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
US5391732A (en) * | 1993-09-16 | 1995-02-21 | Roussel-Uclaf | Process for the preparation of biphenyl-imidazole derivatives |
EP0648763A1 (en) * | 1993-10-19 | 1995-04-19 | Roussel Uclaf | Process for the preparation of sulfur derivatives of imidazole and intermediates obtained |
WO1995023791A1 (en) * | 1994-03-04 | 1995-09-08 | Roussel Uclaf | Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
US5482957A (en) * | 1991-01-04 | 1996-01-09 | Hoechst Aktiengesellschaft | Azole derivatives, process for their preparation and their use |
US5604251A (en) * | 1992-03-07 | 1997-02-18 | Hoechst Aktiengesellschaft | Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain and their use as angitensin II receptors |
EP0855392A2 (en) * | 1997-01-22 | 1998-07-29 | Hoechst Aktiengesellschaft | Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2716882B1 (en) | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Use of imidazole derivatives for the treatment of conditions involving the AT1 and AT2 receptors of Angiotensin, some of these products, their preparation, pharmaceutical compositions. |
DE19540995A1 (en) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituted sulfonimidamides, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them |
DE19832428A1 (en) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
DE19832429A1 (en) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
-
1998
- 1998-07-18 DE DE19832429A patent/DE19832429A1/en not_active Withdrawn
-
1999
- 1999-07-10 AU AU50364/99A patent/AU764784B2/en not_active Ceased
- 1999-07-10 PT PT99934669T patent/PT1097140E/en unknown
- 1999-07-10 DE DE59908753T patent/DE59908753D1/en not_active Expired - Lifetime
- 1999-07-10 CA CA002338039A patent/CA2338039A1/en not_active Abandoned
- 1999-07-10 CN CNB998086967A patent/CN1177827C/en not_active Expired - Fee Related
- 1999-07-10 KR KR1020017000751A patent/KR20010070984A/en not_active Application Discontinuation
- 1999-07-10 DK DK99934669T patent/DK1097140T3/en active
- 1999-07-10 ES ES99934669T patent/ES2217779T3/en not_active Expired - Lifetime
- 1999-07-10 JP JP2000560101A patent/JP4567884B2/en not_active Expired - Fee Related
- 1999-07-10 RU RU2001104454/04A patent/RU2246489C2/en not_active IP Right Cessation
- 1999-07-10 AT AT99934669T patent/ATE260901T1/en not_active IP Right Cessation
- 1999-07-10 WO PCT/EP1999/004886 patent/WO2000003994A2/en not_active Application Discontinuation
- 1999-07-10 EP EP99934669A patent/EP1097140B1/en not_active Expired - Lifetime
- 1999-07-10 US US09/743,941 patent/US6372917B1/en not_active Expired - Lifetime
- 1999-07-10 ID IDW20010128A patent/ID27023A/en unknown
- 1999-07-10 HU HU0103184A patent/HUP0103184A3/en unknown
- 1999-07-10 BR BR9912139-5A patent/BR9912139A/en not_active IP Right Cessation
- 1999-07-10 MX MXPA01000534A patent/MXPA01000534A/en not_active IP Right Cessation
- 1999-07-10 PL PL99346165A patent/PL346165A1/en not_active Application Discontinuation
- 1999-07-10 TR TR2001/00123T patent/TR200100123T2/en unknown
- 1999-07-15 AR ARP990103485A patent/AR019404A1/en not_active Application Discontinuation
-
2001
- 2001-01-11 ZA ZA200100318A patent/ZA200100318B/en unknown
- 2001-12-27 HK HK01109111A patent/HK1038352A1/en not_active IP Right Cessation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0479479A1 (en) * | 1990-10-01 | 1992-04-08 | Merck & Co. Inc. | Imadazole angiotensin II antagonists incorporating acidic functional groups |
US5482957A (en) * | 1991-01-04 | 1996-01-09 | Hoechst Aktiengesellschaft | Azole derivatives, process for their preparation and their use |
EP0503838A2 (en) * | 1991-03-08 | 1992-09-16 | Merck & Co. Inc. | Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists |
WO1992020662A1 (en) * | 1991-05-10 | 1992-11-26 | Merck & Co., Inc. | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
US5604251A (en) * | 1992-03-07 | 1997-02-18 | Hoechst Aktiengesellschaft | Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain and their use as angitensin II receptors |
WO1994003435A1 (en) * | 1992-08-06 | 1994-02-17 | E.I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
US5391732A (en) * | 1993-09-16 | 1995-02-21 | Roussel-Uclaf | Process for the preparation of biphenyl-imidazole derivatives |
EP0648763A1 (en) * | 1993-10-19 | 1995-04-19 | Roussel Uclaf | Process for the preparation of sulfur derivatives of imidazole and intermediates obtained |
WO1995023791A1 (en) * | 1994-03-04 | 1995-09-08 | Roussel Uclaf | Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
EP0855392A2 (en) * | 1997-01-22 | 1998-07-29 | Hoechst Aktiengesellschaft | Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them |
Also Published As
Publication number | Publication date |
---|---|
CA2338039A1 (en) | 2000-01-27 |
HUP0103184A2 (en) | 2002-04-29 |
BR9912139A (en) | 2001-04-10 |
DE59908753D1 (en) | 2004-04-08 |
ZA200100318B (en) | 2002-04-11 |
CN1309644A (en) | 2001-08-22 |
AU5036499A (en) | 2000-02-07 |
MXPA01000534A (en) | 2002-06-04 |
US6372917B1 (en) | 2002-04-16 |
PL346165A1 (en) | 2002-01-28 |
DK1097140T3 (en) | 2004-05-24 |
ATE260901T1 (en) | 2004-03-15 |
CN1177827C (en) | 2004-12-01 |
AR019404A1 (en) | 2002-02-20 |
EP1097140B1 (en) | 2004-03-03 |
ID27023A (en) | 2001-02-22 |
JP2002520397A (en) | 2002-07-09 |
PT1097140E (en) | 2004-07-30 |
DE19832429A1 (en) | 2000-01-20 |
HUP0103184A3 (en) | 2002-05-28 |
RU2246489C2 (en) | 2005-02-20 |
HK1038352A1 (en) | 2002-03-15 |
WO2000003994A2 (en) | 2000-01-27 |
JP4567884B2 (en) | 2010-10-20 |
AU764784B2 (en) | 2003-08-28 |
KR20010070984A (en) | 2001-07-28 |
TR200100123T2 (en) | 2001-05-21 |
EP1097140A2 (en) | 2001-05-09 |
ES2217779T3 (en) | 2004-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY121708A (en) | Five- membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic and medicament comprising them | |
CA2350609A1 (en) | N-substituted 2-cyanopyrrolidines | |
CA2123051A1 (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
WO2001096295A3 (en) | 2-cyanopyrrolidine derivatives and their use as medicaments | |
YU24402A (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicamt and pharmaceutical preparations containing said compounds | |
CA2374737A1 (en) | Novel process for synthesis of heteroaryl-substituted urea compounds | |
CA2361998A1 (en) | Aromatic heterocyclic compounds as anti-inflammatory agents | |
CA2269810A1 (en) | N-substituted 2-cyanopyrrolidines | |
WO2000003994A3 (en) | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them | |
MY117875A (en) | Catalyst component dispersion comprising an ionic compound and solid addition polymerization catalysts containing the same | |
CA2169194A1 (en) | Substituted azadioxacycloalkenes and their use as fungicides | |
CA2274592A1 (en) | Pyrazole derivatives | |
CA2040905A1 (en) | Carbohydrate derivatives comprising a trisaccharide unit | |
EP0903339A3 (en) | Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments | |
RS99004A (en) | Pentafluorosulfanyl- benzoylguanidine, method for the production thereof and its tilization as medicament or diagnostic agent and medicament containing same | |
CA2327784A1 (en) | Triazolones with a neuroprotective action | |
WO2000003612A3 (en) | Antimicrobial compositions | |
CA2217710A1 (en) | Cancer metastasis inhibition with n-acetylneuramic acid | |
CA2206366A1 (en) | Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
CA2157855A1 (en) | Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation | |
CA2283507A1 (en) | Process for preparing pyrazole derivatives | |
NZ501492A (en) | Di-amine and tetra-amine derivatives and pharmaceuticals thereof, useful for treating cardiac arrhythmia | |
CA2355119A1 (en) | Synthesis of heteropolyacids | |
WO2004007478A3 (en) | Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use | |
WO1999041308A8 (en) | Integrated additive composition, process for its preparation and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99808696.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999934669 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/00318 Country of ref document: ZA Ref document number: 200100318 Country of ref document: ZA Ref document number: IN/PCT/2001/53/CHE Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-181 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 50364/99 Country of ref document: AU Ref document number: PA/a/2001/000534 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2338039 Country of ref document: CA Ref document number: 2000 560101 Country of ref document: JP Kind code of ref document: A Ref document number: 2338039 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09743941 Country of ref document: US Ref document number: 1020017000751 Country of ref document: KR Ref document number: 2001/00123 Country of ref document: TR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999934669 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-181 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017000751 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 50364/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999934669 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017000751 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-181 Country of ref document: CZ |